Loading…

Applicability of the UK DCD risk score in the modern era of liver transplantation: A U.S. update

Background Careful graft and recipient selection have resulted in improved outcomes in liver transplantation (LT) using donation after cardiac death (DCD) organs. The UK DCD Risk Score was established as a risk stratification tool to guide selection. Methods We evaluated the applicability of the UK...

Full description

Saved in:
Bibliographic Details
Published in:Clinical transplantation 2022-04, Vol.36 (4), p.e14579-n/a
Main Authors: Wu, W. Kelly, Ziogas, Ioannis A., Matsuoka, Lea K., Izzy, Manhal, Alexopoulos, Sophoclis P.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Careful graft and recipient selection have resulted in improved outcomes in liver transplantation (LT) using donation after cardiac death (DCD) organs. The UK DCD Risk Score was established as a risk stratification tool to guide selection. Methods We evaluated the applicability of the UK DCD Risk Score in a contemporary US cohort of adult DCD LT recipients using the United Network for Organ Sharing registry (2011‐2020). Results A total of 3,899 DCD LTs were included in our study (UK DCD Risk Score 0–5 points: 1,438 [36.9%], 6–10 points: 2,034 [52.2%]; 11–20 points: 427 [11.0%]). Compared to a score of 6–10 points, a score of 0–5 points was associated with decreased risk of graft loss (HR = .79, 95%CI: .68‐.93, p = .004), while a score of 11–20 points was associated with increased risk of graft loss (HR = 1.26, 95%CI: 1.01‐1.56, p = .04). The 5‐year graft survival for patients with risk scores of 0–5, 6–10, and 11–20 were 75.9%, 71.8%, and 66.5%, respectively. The C‐statistic for the UK DCD Risk Score in our contemporary cohort was .611. Conclusions The UK DCD Risk Score demonstrates a more limited ability to differentiate recipient outcomes in the modern era of DCD LT in the US. Acceptable long‐term outcomes are achievable for patients stratified to the highest‐risk group.
ISSN:0902-0063
1399-0012
DOI:10.1111/ctr.14579